Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2008

Open Access 01-12-2008 | Research article

Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO

Authors: Miranda AL van Tilburg, Olafur S Palsson, Rona L Levy, Andrew D Feld, Marsha J Turner, Douglas A Drossman, William E Whitehead

Published in: BMC Complementary Medicine and Therapies | Issue 1/2008

Login to get access

Abstract

Background

Functional Bowel Disorders (FBD) are chronic disorders that are difficult to treat and manage. Many patients and doctors are dissatisfied with the level of improvement in symptoms that can be achieved with standard medical care which may lead them to seek alternatives for care. There are currently no data on the types of Complementary and Alternative Medicine (CAM) used for FBDs other than Irritable Bowel Syndrome (IBS), or on the economic costs of CAM treatments. The aim of this study is to determine prevalence, types and costs of CAM in IBS, functional diarrhea, functional constipation, and functional abdominal pain.

Methods

1012 Patients with FBD were recruited through a health care maintenance organization and followed for 6 months. Questionnaires were used to ascertain: Utilization and expenditures on CAM, symptom severity (IBS-SS), quality of life (IBS-QoL), psychological distress (BSI) and perceived treatment effectiveness. Costs for conventional medical care were extracted from administrative claims.

Results

CAM was used by 35% of patients, at a median yearly cost of $200. The most common CAM types were ginger, massage therapy and yoga. CAM use was associated with female gender, higher education, and anxiety. Satisfaction with physician care and perceived effectiveness of prescription medication were not associated with CAM use. Physician referral to a CAM provider was uncommon but the majority of patients receiving this recommendation followed their physician's advice.

Conclusion

CAM is used by one-third of FBD patients. CAM use does not seem to be driven by dissatisfaction with conventional care. Physicians should discuss CAM use and effectiveness with their patients and refer patients if appropriate.
Literature
1.
go back to reference Tindle HA, Davis RB, Phillips RS, Eisenberg DM: Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005, 11: 42-49.PubMed Tindle HA, Davis RB, Phillips RS, Eisenberg DM: Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005, 11: 42-49.PubMed
2.
go back to reference Cauffield JS: The psychosocial aspects of complementary and alternative medicine. Pharmacotherapy. 2000, 20: 1289-1294. 10.1592/phco.20.17.1289.34898.CrossRefPubMed Cauffield JS: The psychosocial aspects of complementary and alternative medicine. Pharmacotherapy. 2000, 20: 1289-1294. 10.1592/phco.20.17.1289.34898.CrossRefPubMed
3.
go back to reference Rome III: The Functional Gastrointestinal Disorders. Edited by: D.A. D, Corazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG and Whitehead W. 2006, Degnon Associates, 3rd Rome III: The Functional Gastrointestinal Disorders. Edited by: D.A. D, Corazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG and Whitehead W. 2006, Degnon Associates, 3rd
4.
go back to reference Saito YA, Schoenfeld P, Locke GR: The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002, 97: 1910-1915.PubMed Saito YA, Schoenfeld P, Locke GR: The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002, 97: 1910-1915.PubMed
5.
go back to reference Nyrop KA, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ, Whitehead WE: Costs of health care for Irritable Bowel Syndrome, Chronic Constipation, Functional Abdominal Diarrhea, and Functional Abdominal Pain. Aliment Pharmacol Ther. 2007, 26: 237-248.CrossRefPubMed Nyrop KA, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ, Whitehead WE: Costs of health care for Irritable Bowel Syndrome, Chronic Constipation, Functional Abdominal Diarrhea, and Functional Abdominal Pain. Aliment Pharmacol Ther. 2007, 26: 237-248.CrossRefPubMed
6.
go back to reference Hunt RH, Dhaliwal S, Tougas G, Pedro C, Labbe JF, Paul H, Ennamorato M: Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study. Can J Gastroenterol. 2007, 21: 31-37.CrossRefPubMedPubMedCentral Hunt RH, Dhaliwal S, Tougas G, Pedro C, Labbe JF, Paul H, Ennamorato M: Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study. Can J Gastroenterol. 2007, 21: 31-37.CrossRefPubMedPubMedCentral
7.
go back to reference Koloski NA, Talley NJ, Huskic SS, Boyce PM: Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2003, 17: 841-851. 10.1046/j.1365-2036.2003.01498.x.CrossRefPubMed Koloski NA, Talley NJ, Huskic SS, Boyce PM: Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2003, 17: 841-851. 10.1046/j.1365-2036.2003.01498.x.CrossRefPubMed
8.
go back to reference Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, Bramble MG, McAlindon ME, Sanders DS: The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol. 2005, 39: 138-141. 10.1097/01.mcg.0000155570.19340.61.CrossRefPubMed Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, Bramble MG, McAlindon ME, Sanders DS: The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol. 2005, 39: 138-141. 10.1097/01.mcg.0000155570.19340.61.CrossRefPubMed
9.
10.
go back to reference Hussain Z, Quigley EM: Systematic review: Complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther. 2006, 23: 465-471. 10.1111/j.1365-2036.2006.02776.x.CrossRefPubMed Hussain Z, Quigley EM: Systematic review: Complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther. 2006, 23: 465-471. 10.1111/j.1365-2036.2006.02776.x.CrossRefPubMed
11.
go back to reference Webb AN, Kukuruzovic RH, Catto-Smith AG, Sawyer SM: Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2007, CD005110- Webb AN, Kukuruzovic RH, Catto-Smith AG, Sawyer SM: Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2007, CD005110-
12.
go back to reference Liu JP, Yang M, Liu YX, Wei ML, Grimsgaard S: Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006, CD004116- Liu JP, Yang M, Liu YX, Wei ML, Grimsgaard S: Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006, CD004116-
13.
go back to reference Lim B, Manheimer E, Lao L, Ziea E, Wisniewski J, Liu J, Berman B: Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006, CD005111- Lim B, Manheimer E, Lao L, Ziea E, Wisniewski J, Liu J, Berman B: Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006, CD005111-
14.
go back to reference Whitehead WE, Levy RL, Von KM, Feld AD, Palsson OS, Turner M, Drossman DA: The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther. 2004, 20: 1305-1315. 10.1111/j.1365-2036.2004.02256.x.CrossRefPubMed Whitehead WE, Levy RL, Von KM, Feld AD, Palsson OS, Turner M, Drossman DA: The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther. 2004, 20: 1305-1315. 10.1111/j.1365-2036.2004.02256.x.CrossRefPubMed
15.
go back to reference Means B, Nigam A, Zarrow M, Loftus EF, Donaldson MS: Autobiographical memory for health related events. DHHS publication N. PHS 89-1077.ed. 1989, Washington, DC, U.S. Government Printing Office Means B, Nigam A, Zarrow M, Loftus EF, Donaldson MS: Autobiographical memory for health related events. DHHS publication N. PHS 89-1077.ed. 1989, Washington, DC, U.S. Government Printing Office
16.
go back to reference Whitehead WE, Palsson OS, Levy RL, Feld AD, VonKorff M, Turner M: Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol. 2006, 101: 1057-1065. 10.1111/j.1572-0241.2006.00535.x.CrossRefPubMed Whitehead WE, Palsson OS, Levy RL, Feld AD, VonKorff M, Turner M: Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol. 2006, 101: 1057-1065. 10.1111/j.1572-0241.2006.00535.x.CrossRefPubMed
17.
go back to reference Francis CY, Morris J, Whorwell PJ: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997, 11: 395-402. 10.1046/j.1365-2036.1997.142318000.x.CrossRefPubMed Francis CY, Morris J, Whorwell PJ: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997, 11: 395-402. 10.1046/j.1365-2036.1997.142318000.x.CrossRefPubMed
18.
go back to reference Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu YM, Jia HG, Bangdiwala SI: Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire. American Journal of Gastroenterology. 2000, 95: 999-1007. 10.1111/j.1572-0241.2000.01941.x.CrossRefPubMed Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu YM, Jia HG, Bangdiwala SI: Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire. American Journal of Gastroenterology. 2000, 95: 999-1007. 10.1111/j.1572-0241.2000.01941.x.CrossRefPubMed
19.
go back to reference Derogatis LR: Brief Symptom Inventory (BSI) administration, scoring, and procedures manual (3rd ed). 1993, Minneapolis, NCS Pearson, Inc. Derogatis LR: Brief Symptom Inventory (BSI) administration, scoring, and procedures manual (3rd ed). 1993, Minneapolis, NCS Pearson, Inc.
20.
go back to reference Ernst E, Pittler MH: Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000, 84: 367-371.CrossRefPubMed Ernst E, Pittler MH: Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000, 84: 367-371.CrossRefPubMed
21.
go back to reference Grzanna R, Lindmark L, Frondoza CG: Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005, 8: 125-132. 10.1089/jmf.2005.8.125.CrossRefPubMed Grzanna R, Lindmark L, Frondoza CG: Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005, 8: 125-132. 10.1089/jmf.2005.8.125.CrossRefPubMed
22.
go back to reference Pittler MH, Ernst E: Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol. 1998, 93: 1131-1135. 10.1111/j.1572-0241.1998.00343.x.CrossRefPubMed Pittler MH, Ernst E: Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol. 1998, 93: 1131-1135. 10.1111/j.1572-0241.1998.00343.x.CrossRefPubMed
23.
go back to reference Tan G, Hammond DC, Joseph G: Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn. 2005, 47: 161-178.CrossRefPubMed Tan G, Hammond DC, Joseph G: Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn. 2005, 47: 161-178.CrossRefPubMed
24.
go back to reference Haas L, McClain C, Varilek G: Complementary and alternative medicine and gastrointestinal diseases. Curr Opin Gastroenterol. 2000, 16: 188-196. 10.1097/00001574-200003000-00016.CrossRefPubMed Haas L, McClain C, Varilek G: Complementary and alternative medicine and gastrointestinal diseases. Curr Opin Gastroenterol. 2000, 16: 188-196. 10.1097/00001574-200003000-00016.CrossRefPubMed
25.
go back to reference Zuckerman MJ: The role of fiber in the treatment of irritable bowel syndrome: therapeutic recommendations. J Clin Gastroenterol. 2006, 40: 104-108. 10.1097/01.mcg.0000196405.15110.bb.CrossRefPubMed Zuckerman MJ: The role of fiber in the treatment of irritable bowel syndrome: therapeutic recommendations. J Clin Gastroenterol. 2006, 40: 104-108. 10.1097/01.mcg.0000196405.15110.bb.CrossRefPubMed
26.
go back to reference Camilleri M: Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006, 40: 264-269. 10.1097/00004836-200603000-00020.CrossRefPubMed Camilleri M: Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006, 40: 264-269. 10.1097/00004836-200603000-00020.CrossRefPubMed
27.
go back to reference Koretz RL, Rotblatt M: Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin Gastroenterol Hepatol. 2004, 2: 957-967. 10.1016/S1542-3565(04)00461-6.CrossRefPubMed Koretz RL, Rotblatt M: Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin Gastroenterol Hepatol. 2004, 2: 957-967. 10.1016/S1542-3565(04)00461-6.CrossRefPubMed
Metadata
Title
Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO
Authors
Miranda AL van Tilburg
Olafur S Palsson
Rona L Levy
Andrew D Feld
Marsha J Turner
Douglas A Drossman
William E Whitehead
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2008
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-8-46

Other articles of this Issue 1/2008

BMC Complementary Medicine and Therapies 1/2008 Go to the issue